Skip to main content
TipRanks
Go Ultimate75% OFF

Delorean Corporation Ltd (DEL) AI Stock Analysis

21 Followers
AU:DEL

Delorean Corporation Ltd

(ASX:DEL)

Select Model
Rating:38Underperform
Price Target:AUD 0.07â–¼(-5.56% Downside)
Action:reiterated
Date:11/18/26

The overall score is extremely low, driven primarily by a severe financial deterioration that threatens the company's viability. Collapsing revenues, deep negative gross margins, and a massive cash burn are compounded by an unsustainable debt load. The weak technical trend and negative valuation metrics reinforce the poor outlook, leaving no positive catalysts to offset the risks.

Positive Factors
Renewable Waste-to-Energy ModelThe company addresses two persistent needs through one operating model: organic-waste treatment and renewable energy production. Owning and operating biogas infrastructure can support recurring project-level activity while linking energy generation with emissions-reduction outcomes over several quarters.
Negative Factors
Revenue and Margin DeteriorationSharp revenue contraction and persistently negative gross and operating margins show that the business has not yet converted its project model into durable profitability. Continued weakness limits internal funding capacity and makes future earnings more dependent on successful project execution.

Delorean Corporation Ltd (DEL) vs. iShares MSCI Australia ETF (EWA)

-60%-40%-20%0%20%40%AU:DEL-48.57%EWA+16.41%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
AUD 18.98M
Dividend Yield
―
Average Volume (3M)
103.89K
Price to Earnings (P/E)
-17.6
Beta (1Y)
0.13
Revenue Growth
-52.16%
EPS Growth
96.81%
Country
Australia
Employees
28
Sector
Utilities
Sector Strength
66
Industry
Renewable Utilities

Delorean Corporation Ltd Business Overview & Revenue Model

Company Description

Delorean Corporation Limited is an Australian enterprise deeply involved in the renewable energy and waste management industries across both Australia and New Zealand. Its comprehensive business model is segmented into Infrastructure, Engineering, En...

How the Company Makes Money

Delorean Corporation’s revenue model is based on monetising biogas and the energy and environmental attributes derived from it. Key revenue streams include: (1) electricity generation revenue from converting captured biogas into power and selling tha...

Delorean Corporation Ltd Financial Statement Overview

Summary

Financial health is critically poor. Revenue collapsed 40% to $8.5M, gross margins are deeply negative at -38%, and the balance sheet is saddled with $49.9M in debt against only $7.5M in equity. Free cash flow is a massive -$22.8M, indicating a severe cash burn that threatens solvency.

Income Statement

8Very Negative

Balance Sheet

5Very Negative

Cash Flow

10Very Negative
Financial statement breakdown
BreakdownTTMJun 2026Jun 2025Jun 2024Jun 2023Jun 2022
Income Statement
Total Revenue8.54M8.54M19.83M27.88M19.25M39.33M
Gross Profit-3.25M-3.25M-2.99M7.83M-7.18M-6.77M
EBITDA-4.03M-4.03M-6.13M5.04M-9.06M-11.87M
Net Income-916.03K-916.03K-6.55M4.77M-10.02M-10.89M
Balance Sheet
Total Assets63.97M63.97M48.30M28.05M17.92M24.10M
Cash, Cash Equivalents and Short-Term Investments5.41M5.41M10.66M8.84M1.00M3.12M
Total Debt49.89M49.89M31.31M9.07M7.62M2.63M
Total Liabilities55.66M55.66M40.45M19.28M15.75M12.21M
Stockholders Equity8.31M8.31M7.85M8.77M2.17M11.88M
Cash Flow
Free Cash Flow-22.83M-22.83M-21.50M6.89M-6.80M-15.21M
Operating Cash Flow-1.69M-1.69M-5.66M7.24M-5.36M-11.77M
Investing Cash Flow-19.34M-19.34M-15.08M-3.92M-1.44M-3.44M
Financing Cash Flow17.29M17.29M23.33M915.22K4.68M5.26M

Delorean Corporation Ltd Technical Analysis

Technical Analysis SentimentNegative
Last Price0.07

Price Trends

50DMA0.09Negative
100DMA0.09Negative
200DMA0.09Negative

Market Momentum

MACD-0.00Positive
RSI37.68Neutral
STOCH24.24Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:DEL, the sentiment is Negative. The current price of 0.07 is below the 20-day moving average (MA) of 0.08, below the 50-day MA of 0.09, and below the 200-day MA of 0.09, indicating a bearish trend. The MACD of -0.00 indicates Positive momentum. The RSI at 37.68 is Neutral, neither overbought nor oversold. The STOCH value of 24.24 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for AU:DEL.

Delorean Corporation Ltd Peers Comparison

Overall Rating

UnderperformOutperform
Sector (66)

Financial Indicators

AU:DEL against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
Sector *66Neutral$17.65B18.105.60%3.62%6.62%11.55%
AU:VPRAU:VPR63NeutralAUD 17.94M9.9112.83%―57.73%30.59%
AU:CCEAU:CCE55NeutralAUD 72.64M-24.29-14.42%―42.98%-9.38%
AU:JNSAU:JNS44NeutralAUD 111.41M-7.80-718.72%―27.74%49.26%
AU:KPOAU:KPO44NeutralAUD 33.67M2.0065.86%―――
AU:DELAU:DEL38UnderperformAUD 19.72M-17.56-15.03%―-52.16%96.81%
AU:14DAU:14D37UnderperformAUD 17.58M-1.53-138.53%――-29.75%

* Utilities Sector Average

Performance Comparison

0%200%400%AU:DELAU:CCEAU:JNSAU:KPOAU:14DAU:VPRDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
AU:DEL and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
AU:DELDelorean Corporation Ltd0.07-0.08-52.00%
AU:CCECarnegie Clean Energy Ltd0.170.10129.73%
AU:JNSReNu Energy Limited0.590.42247.06%
AU:KPOKalina Power Limited0.01-0.01-42.11%
AU:14D1414 Degrees Ltd.0.020.004.35%
AU:VPRVolt Power Group Ltd0.11-0.04-26.67%

Delorean Corporation Ltd Corporate Events

Delorean Issues Shares Under Placement and Cleansing Notice

Nov 16, 2026

Delorean Corporation Ltd (ASX: DEL) issued 20,895,523 fully paid ordinary shares at $0.067 each under a placement announced on 9 November 2026. The company issued the shares without disclosure under Part 6D.2 and gave a cleansing notice under section...

Delorean Applies to Quote 20,895,523 Fully Paid Ordinary Shares

Nov 16, 2026

Delorean Corporation Limited applied for ASX quotation of 20,895,523 fully paid ordinary securities under issuer code DEL. The securities have an issue date of 17 November 2026 and were issued as part of transactions previously announced to the marke...

Delorean Proposes Placement of 20.9 Million Shares

Nov 8, 2026

Delorean Corporation Limited lodged an ASX announcement proposing a placement of 20,895,523 fully paid ordinary shares under its DEL security code. The proposed issue, announced on 9 November 2026 and scheduled for 17 November 2026, would expand the...

Delorean Reaches Financial Close on $62.1m Bioenergy Facility

Nov 8, 2026

Delorean Corporation operates in Australia’s renewable-energy and bioenergy industry, developing facilities that produce renewable gas for industrial customers. The company reached financial close on its wholly owned $62.1 million Horsley Park Bioene...

Delorean Requests Trading Halt Pending NSW1 Funding Announcement

Nov 4, 2026

Delorean Corporation Limited requested a trading halt for its ordinary shares on 5 November 2026, pending an announcement concerning funding for the NSW1 project. The halt is expected to continue until the funding announcement is released or normal t...

Delorean Details ESG Strategy in 2026 Sustainability Report

Nov 2, 2026

Delorean Corporation has released a voluntary sustainability report outlining its environmental, social, and governance approach, objectives, priority areas, and progress. The company positions sustainability as central to its operations and as a cat...

Delorean advances flagship bioenergy projects with new funding and regulatory milestones

Oct 30, 2026

Delorean reported a quarter-end cash balance of $2.5 million and customer receipts of $0.8 million, while advancing construction of its flagship SA1 Salisbury bioenergy facility to 90% completion. The project secured a key regulatory licence from the...

Delorean sets November date for 2026 AGM and streamlines proxy voting

Oct 27, 2026

Delorean Corporation Ltd has scheduled its 2026 Annual General Meeting of shareholders to be held in person at its West Perth premises on 27 November 2026 at 9:00am AWST. Shareholders are directed to access the Notice of Meeting, Explanatory Memorand...

Delorean Calls 2026 AGM, Seeks Director Re-Elections and Share Placement Ratification

Oct 27, 2026

Delorean Corporation Ltd has called its annual general meeting for 27 November 2026 in West Perth, setting 25 November 2026 as the record date for shareholder voting. The meeting will review the financial report for the year ended 30 June 2026, inclu...

Delorean Wins Licence for Pioneering SA1 Bioenergy Plant

Oct 19, 2026

Delorean Corporation Ltd has secured a key regulatory milestone for its 100% owned SA1 Salisbury Bioenergy Project in South Australia, with the South Australian Environment Protection Authority issuing an operational licence. The facility, about 90%...

Delorean secures Westpac mandate to fund NSW Horsley Park bioenergy project

Oct 12, 2026

Delorean Corporation has entered into a non-binding financing agreement and mandate with Westpac Banking Corporation for $20 million to fund capital plant and equipment for its NSW1 Horsley Park Bioenergy Project in Western Sydney. The project, co-lo...

Delorean Corporation Updates Market on Director’s Expired Performance Shares

Oct 9, 2026

Delorean Corporation Ltd, an Australian listed company, holds its equity interests through family and superannuation structures associated with director Hamish Jolly, including Dunbar-Harper Pty Ltd and Antediluvian Pty Ltd. The company’s capital str...

Delorean Corporation Cuts Dilution as Over 9 Million Performance Rights Expire

Oct 9, 2026

Delorean Corporation Ltd has notified the market of the cessation of a large tranche of performance rights on its register. The company reported that 9,114,476 DELAA performance rights have lapsed, following expiry without being exercised or converte...

Delorean Sets Date and Director Nomination Deadline for 2026 AGM

Oct 6, 2026

Delorean Corporation Ltd has scheduled its 2026 Annual General Meeting for 9:00 a.m. AWST on Friday, 27 November 2026, in Perth, and has set 13 October 2026 as the closing date for director nomination submissions. The company will provide further AGM...

Delorean Corporation Lodges Appendix 4G, Confirms Governance Compliance

Sep 30, 2026

Delorean Corporation Ltd has lodged its Appendix 4G and confirmed that its corporate governance statement for the year ended 30 June 2026 is available on its website. The statement, approved by the board as at 30 September 2026, outlines compliance w...

Delorean Details 2026 Corporate Governance Framework and Board Oversight

Sep 30, 2026

Delorean Corporation Ltd has detailed its 2026 corporate governance practices, reaffirming a commitment to high standards under the ASX Corporate Governance Principles. The Board’s charter defines responsibilities spanning long-term strategy, financi...

Delorean Targets Emerging Market for Renewable Natural Gas in Australia

Sep 30, 2026

Delorean Corporation Ltd operates in Australia’s renewable energy sector, focusing on bioenergy and renewable natural gas. The company is building infrastructure and partnerships to supply lower-carbon gas solutions, targeting hard-to-abate industria...

Delorean and Opal Advance $35m Bioenergy Project at Maryvale Mill

Sep 22, 2026

Delorean Corporation and Paper Australia’s Opal have completed the Concept Stage of their collaboration to develop a bioenergy facility at Opal’s Maryvale Mill in Victoria, advancing plans to convert organic residues and paper by-products into renewa...

Delorean advances BOO renewable gas strategy as losses narrow and assets grow

Aug 31, 2026

Delorean reported FY26 revenue of $8.5 million, down 56% from FY25, but delivered a positive EBITDA of $0.18 million and cut its total comprehensive loss after tax to $0.9 million, an 86% improvement. Total assets rose to $63 million and cash and ter...

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Nov 18, 2026